Status:
COMPLETED
Intensive Care Therapy of Covid-19 Disease in Germany
Lead Sponsor:
University Hospital Tuebingen
Conditions:
COVID
ARDS
Eligibility:
All Genders
18+ years
Brief Summary
Multi-center retrospective and prospective observational study of Covid-19 patients with severe or critical illness treated on a German ICU
Eligibility Criteria
Inclusion
- Age above 18 years
- Covid-19 disease (positive SARS-CoV-2 PCR)
Exclusion
- none
Key Trial Info
Start Date :
August 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
2054 Patients enrolled
Trial Details
Trial ID
NCT04455451
Start Date
August 6 2020
End Date
September 30 2021
Last Update
January 12 2022
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
RWTH Aachen - Department for operative Intensive Care Medicine and intermediate Care
Aachen, Germany
2
Zollernalbklinikum
Balingen, Germany
3
Charité Universitätsmedizin Berlin
Berlin, Germany
4
UH Bochum - Department for Anesthesiology and Intensive Care Medicine
Bochum, Germany